BioGaia probiotic cuts sick days

Related tags L. reuteri Lactobacillus Digestive system Gut flora

A daily probiotic supplement reduced the number of sick days caused
by gastrointestinal illnesses or colds by almost 70 per cent,
according to a new study done by Swedish firm BioGaia.

The company provided supplements containing its L. reuteri protectis bacteria for a study on 181 subjects working at two different places in Sweden.

L. reuteri protectis​ is a bacterium that is naturally found in the human intestine, and is the one marketed in numerous products globally by BioGaia.

The double-blind, placebo-controlled, randomised study found that daily consumption of a portion-pack drink containing the probiotic in the firm's LifeTop straw halved the number of subjects reporting sick leave due to gastrointestinal illness or colds over a three-month period.

In the placebo group, sick leave due to these illnesses was 0.9 per ent of working days, whilst in the Reuteri group this was reduced to 0.3 per cent. These differences were highly statistically significant.

"The result is revolutionary and has a major implication for public health,"​ said Peter Rothschild, managing director of BioGaia​.

"We have had similar results from a study in day-care children where health frequency was also significantly improved by Reuteri bacteria. Now we have confirmation that Reuteri gives the same health-promoting effect also in adults,"​ he added.

"If the product is consumed regularly by the Swedish working population, we could increase the number of working days by 5 million per year in Sweden,"​ continued Rothschild.

The study has not yet been published. For further details, contact BioGaia.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Follow us


View more